A prospective study exploring the predictors of response to benralizumab in patients with refractory bronchial asthma.

Hirose, Masahiro; Kuwabara, Kazunobu; Kondo, Rieko; Horiguchi, Takahiko

Hirose, Masahiro; Kuwabara, Kazunobu; Kondo, Rieko; Horiguchi, Takahiko.

Afiliação

Hirose M; Department of Respiratory Medicine II, Fujita Health University, School of Medicine, Nagoya, Aichi, Japan.
Kuwabara K; Department of Respiratory Medicine II, Fujita Health University, School of Medicine, Nagoya, Aichi, Japan.
Kondo R; Department of Respiratory Medicine II, Fujita Health University, School of Medicine, Nagoya, Aichi, Japan.
Horiguchi T; Department of Respiratory Medicine II, Fujita Health University, School of Medicine, Nagoya, Aichi, Japan.

Fujita Med J ; 8(1): 13-16, 2022 Feb.

Article em En | MEDLINE | ID: mdl-35233342

Palavras-chave

Anti-IL-5 receptor α monoclonal antibody; Antibody preparation; Benralizumab; Refractory bronchial asthma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Fujita Med J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google